Dicot reduces costs by moving manufacturing step
Uppsala, October 25, 2022. Dicot is moving parts of the manufacturing of its drug substance to lower costs and reduce transportations. It is the extraction process that is being moved to South Africa where the starting material is already handled and where the company has established collaboration partners.The active substance in Dicot's drug candidate is a semi-synthetic molecule whose starting material is from nature. To manufacture the medicinal substance, the starting point is seeds that undergo an extraction process followed by a number of synthesis steps. The seeds come primarily